Should Failure to Disclose Significant Financial Conflicts of Interest Be Considered Research Misconduct?

JAMA - Journal of the American Medical Association

Volumn 320, Issue 22, 2018, Pages 2307-2308

  Botkin, Jeffrey R ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FINANCIAL MANAGEMENT; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HEALTH SERVICE; HUMAN; NOTE; ORGANIZATIONAL POLICY; PERSONAL INCOME; PRIORITY JOURNAL; PROFESSIONAL STANDARD; PROTOCOL COMPLIANCE; SCIENTIFIC MISCONDUCT; ADVISORY COMMITTEE; CONFLICT OF INTEREST; ETHICS; GOVERNMENT REGULATION; INTERPERSONAL COMMUNICATION; LEGISLATION AND JURISPRUDENCE; MEDICAL RESEARCH; ORGANIZATION; PUBLIC POLICY; PUBLISHING; UNITED STATES; WRITING;

ACADEMIES AND INSTITUTES; ADVISORY COMMITTEES; AUTHORSHIP; BIOMEDICAL RESEARCH; CONFLICT OF INTEREST; DISCLOSURE; EDITORIAL POLICIES; GOVERNMENT REGULATION; PUBLIC POLICY; SCIENTIFIC MISCONDUCT; UNITED STATES;

EID: 85055533859     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2018.17525     Document Type: Note

References (10)

1. Ornstein C, Thomas K. Top cancer researcher fails to disclose corporate financial ties in major research journals. New York Times. https://www.nytimes.com/2018/09/08/health/jose-baselga-cancer-memorial-sloan-kettering.html. Published September 8, 2018. Accessed October 11, 2018.
2. Lo B, Field MJ, eds. Conflict of Interest in Medical Research, Education, and Practice. Washington, DC: National Academies Press; 2009.
3. Falk Delgado A, Falk Delgado A. Self-declared stock ownership and association with positive trial outcome in randomized controlled trials with binary outcomes published in general medical journals: a cross-sectional study. Trials. 2017; 18 (1): 354. doi: 10.1186/s13063-017-2108-z 28747226
4. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003; 289 (4): 454-465. doi: 10.1001/jama.289.4.454 12533125
5. Lo B, Grady D. Payments to physicians: does the amount of money make a difference? JAMA. 2017; 317 (17): 1719-1720. doi: 10.1001/jama.2017.1872 28464150
6. Fineberg HV. Conflict of interest: why does it matter? JAMA. 2017; 317 (17): 1717-1718. doi: 10.1001/jama.2017.1869 28464149
7. Waldstreicher J, Johns ME. Managing conflicts of interest in industry-sponsored clinical research: more physician engagement is required. JAMA. 2017; 317 (17): 1751-1752. doi: 10.1001/jama.2017.4160 28464168
8. Public Health Service, Department of Health and Human Services. Responsibility of applicants for promoting objectivity in research for which PHS funding is sought. 42 CFR Part 50, Subpart F. https://grants.nih.gov/grants/compliance/42-cfr-50-subpart-f.htm. Accessed October 11, 2018.
9. AAMC-AAU Advisory Committee on Financial Conflicts of Interest in Human Subjects Research. Protecting patients, preserving integrity, advancing health: accelerating the implementation of coi policies in human subjects research. https://www.aamc.org/download/482216/data/protectingpatients.pdf. Published 2008. Accessed October 11, 2018.
10. Office of Research Integrity. Federal research misconduct policy. Federal Register. https://ori.hhs.gov/federal-research-misconduct-policy. Published December 6, 2000. Accessed October 11, 2018.